| First Author | Hayashi S | Year | 2020 |
| Journal | J Invest Dermatol | Volume | 140 |
| Issue | 10 | Pages | 2001-2008 |
| PubMed ID | 32109455 | Mgi Jnum | J:297485 |
| Mgi Id | MGI:6472814 | Doi | 10.1016/j.jid.2020.01.028 |
| Citation | Hayashi S, et al. (2020) Anti-Inflammatory Effects of Potassium Iodide on SDS-Induced Murine Skin Inflammation. J Invest Dermatol 140(10):2001-2008 |
| abstractText | Potassium iodide (KI), initially derived from seaweed in the early 19th century, is used for treating sporotrichosis in dermatological practice. KI has also been used to treat several noninfectious inflammatory skin diseases. However, the mechanisms underlying the improvement in such skin diseases remain unknown, and KI is not used widely. Thus, although KI is an old drug, physicians may not prescribe it frequently because they lack knowledge about it. Although KI is very inexpensive and causes few side effects, it has been superseded by new powerful and expensive drugs, such as biological agents. We applied 3% KI topically to areas of inflammation induced by SDS in mice. The levels of IL-1 and TNF-alpha gene expression were reduced, whereas that of IL-10 gene expression was increased. Small interfering RNA that was designed to reduce IL-10 gene expression levels was injected into the same mice, and the anti-inflammatory effects of KI were not observed. Thus, the pharmacologic action of KI is based on its anti-inflammatory effects caused by the increase in IL-10 levels. This information would increase dermatologists' awareness of KI as an efficacious and cost-effective treatment. |
